20 reports

Coronary Artery Disease Phase ## Clinical Trials, 2016 ##.

  • Coronary Artery Disease
  • France
  • Germany
  • United States
  • Market Size

Coronary Artery Disease Phase ## Clinical Trials, 2016 ##.

  • Coronary Artery Disease
  • France
  • Germany
  • Italy
  • Market Size

Coronary Artery Disease Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • United States
  • Market Size

Coronary Artery Disease Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • Japan
  • Market Size

Coronary Artery Disease Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • United Kingdom
  • Market Size

Coronary Artery Disease Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • Germany
  • Market Size

Coronary Artery Disease Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • France
  • Market Size

Coronary Artery Disease Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • Italy
  • Market Size

Coronary Artery Disease Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • Spain
  • Market Size
  • Coronary artery disease
  • Procedure used to treat coronary artery disease

About coronary artery disease Coronary artery disease, also known as coronary heart disease, is a narrowing or blockage of coronary arteries. Coronary arteries provide oxygen-rich blood to the heart muscles. PTCA is a minimally invasive procedure used to remove the blockage of coronary arteries. The procedure involves the usage of stents,...

  • Coronary Artery Disease
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Terumo Corporation
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF CHRONIC CORONARY ARTERY DISEASE (CAD) (ISCHEMIC HEART DISEASE) TO CARDIOVASCULAR CLINICAL TRIALS
  • LATEST CLINICAL TRIALS NEWS ON CHRONIC CORONARY ARTERY DISEASE (CAD) (ISCHEMIC HEART DISEASE)

Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Coronary Artery Disease (CAD) (Ischemic...

  • Cardiology
  • Cardiovascular Disease
  • Coronary Artery Disease
  • World
  • Product Initiative
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Phase (%), 2016*

Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016" provides an overview of Occlusive Coronary Artery Disease clinical trials scenario. This report provides top line data relating...

  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • World
  • Product Initiative
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Dormant Projects
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Overview

Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2017, provides an overview of the Coronary Artery Disease (CAD) (Ischemic...

  • Cardiovascular Disease
  • Coronary Artery Disease
  • Therapy
  • United States
  • Product Initiative

Coronary Artery Disease Pipeline Highlights – 2017 ##.

  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • Product Initiative
  • Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials and Average
  • Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by

Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Coronary Artery Disease (CAD) (Ischemic...

  • Cardiovascular Disease
  • Coronary Artery Disease
  • Therapy
  • World
  • Product Initiative
  • 9.2 CORONARY ARTERY DISEASE
  • CORONARY ARTERY DISEASES TO WITNESS HIGHEST GROWTH DURING THE

“Bioresorbable stents market projected to grow at a CAGR of 11.5% from 2017 to 2022” The global bioresorbable stents market is expected to reach USD 417.2 million by 2022 from USD 223.6 million in 2016, at a CAGR of 11.5% during the forecast period. Growing aging population susceptible to coronary and peripheral artery diseases,...

  • Coronary Artery Disease
  • North America
  • United States
  • Forecast
  • Boston Scientific Corporation

Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H## 2015 Table of Contents Table of Contents ## List of Tables ## List of Figures ## Introduction ## Global Markets Direct Report Coverage ## Chronic Coronary Artery

  • Cardiovascular Disease
  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • World

Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H## 2015 Table of Contents Introduction ## Global Markets Direct Report Coverage ## Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Ov

  • Cardiovascular Disease
  • Chronic Disease
  • Coronary Artery Disease
  • Pathology
  • World
  • Coronary Artery Disease Overview
  • Prevalence of Coronary Artery Disease by Gender (2014)

The stent market is an important segment of the coronary heart diseases. The stent is a small, elastic, mesh like tube made of a metal stainless steel or cobalt alloy that acts as support. Stents are attached onto small balloons and opened inside the artery to reinstate blood flow and support the vessel wall. Stenting does not involve any...

  • Coronary Artery Disease
  • Implantable Delivery
  • Interventional Cardiology Device
  • World
  • Medtronic, Inc.
  • CARDIODX SECURES USD6 MILLION IN VENTURE FUNDING
  • CARDIODX SECURES USD30.5 MILLION IN VENTURE FUNDING

Summary CardioDx Inc (CardioDx) is a cardiovascular genomic diagnostics company. It undertakes the development of clinically validated tests in the areas of coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD gene expression test is used for assessing obstructive...

  • Cardiovascular Disease
  • Coronary Artery Disease
  • Medical Equipment
  • United States
  • CardioDx, Inc.